Opportunity Information: Apply for RFA HG 22 008
This NIH funding opportunity (RFA-HG-22-008) supports the creation of Disease Study Sites (DSS) under a U01 cooperative agreement, meaning awardees will carry out their projects in close collaboration with NIH and the broader program partners. The overall purpose is to push multi-omics approaches forward in real-world health and disease research, especially in diverse populations. Rather than focusing primarily on discovering brand-new causes of disease, the program is designed to test, validate, and improve generalizable ways of using multi-omics to detect meaningful biological changes tied to health, disease status, and changes over time.
The DSS awards are one part of a larger coordinated initiative that also includes Omics Production Centers (RFA-HG-22-009) and a Data Analysis and Coordination Center (RFA-HG-22-010). In practice, a DSS is expected to bring the clinical context: it proposes and runs a study in a specific disease area where integrated multi-omics is likely to be especially informative. The multi-omics data generated through the program is intended to be analyzed alongside rich phenotypic information and environmental exposure data, explicitly including social determinants of health (SDOH). This integrated approach is central to the FOA, since the goal is to connect molecular patterns with clinical and lived-environment factors in a way that can be compared and reused across diseases and study sites.
Across the consortium, the DSS program has three main objectives. First, it aims to explore how multi-omics, combined with phenotype and exposure/SDOH data, can be used to detect and characterize molecular profiles associated with healthy versus disease states. Second, it aims to develop broadly useful methods for data harmonization, integration, and analysis, along with best practices and standards that make multi-omics studies more consistent, comparable, and scientifically reliable across different settings. Third, it aims to produce a high-value, multi-dimensional dataset that will be made available to the wider research community, supporting downstream discovery and method development beyond the funded sites.
In terms of what a DSS is expected to do, each site is primarily responsible for designing a disease-focused study and then executing it in a way that supports consortium-wide learning. That includes putting strong participant enrollment and consent processes in place, collecting clinical/phenotypic data and environmental exposure measures (including SDOH variables), and collecting biological samples and other measures repeatedly over time when appropriate. Because this is a cooperative agreement within a consortium, DSS teams are also expected to contribute to shared protocol development, collaborative analysis, methods development, and the coordinated production and sharing of the final multi-dimensional dataset.
The FOA is labeled "Clinical Trial Optional," which signals that clinical trials are not required for all projects, but applicants can propose a trial component if it fits the scientific plan and meets NIH requirements. The activity sits within NIH program areas connected to education, environment, and health, and is associated with CFDA numbers 93.113, 93.172, 93.396, and 93.399. The awarding agency is the National Institutes of Health.
Eligibility is broad and includes many U.S.-based organizational types: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other organizations. The FOA also explicitly highlights participation from organizations such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, faith-based and community-based organizations, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities (TCCUs), regional organizations, and U.S. territories or possessions, reflecting the program emphasis on diversity and inclusion in study populations.
Foreign eligibility is limited. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components as defined by the NIH Grants Policy Statement are allowed, meaning a U.S. applicant organization may be able to include certain foreign activities or collaborations if they meet NIH policy requirements and are well-justified within the project scope.
Key administrative details provided include an original closing date of 2022-11-18, a listed award ceiling of $500,000, and an expected awards field that is not specified in the provided text. The opportunity was created on 2022-09-07. Overall, the opportunity is best understood as a consortium-based effort to standardize and strengthen how multi-omics is applied in disease-focused, longitudinal, and population-diverse settings, while producing reusable datasets, methods, and best practices for the broader scientific community.Apply for RFA HG 22 008
- The National Institutes of Health in the education, environment, health sector is offering a public funding opportunity titled "Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.172, 93.396, 93.399.
- This funding opportunity was created on 2022-09-07.
- Applicants must submit their applications by 2022-11-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this NIH funding opportunity?
This is an NIH funding opportunity announcement (FOA) titled RFA-HG-22-008. It funds the creation of Disease Study Sites (DSS) using a U01 cooperative agreement mechanism.
What does it mean that the award is a U01 cooperative agreement?
A U01 cooperative agreement indicates that funded awardees will conduct their projects in close collaboration with NIH and other program partners, rather than operating entirely independently.
What is a Disease Study Site (DSS) in this program?
A DSS is a funded site responsible for proposing and running a study in a specific disease area where integrated multi-omics is expected to be particularly informative. The DSS provides the clinical and study context for the broader consortium.
What is the overall purpose of the DSS program?
The overall purpose is to advance multi-omics approaches in real-world health and disease research, especially in diverse populations. The focus is on testing, validating, and improving generalizable methods for using multi-omics to detect meaningful biological changes tied to health, disease status, and changes over time.
Is the program mainly about discovering brand-new causes of disease?
No. The program is described as being less focused on discovering entirely new causes of disease and more focused on evaluating and improving broadly usable, generalizable approaches for applying multi-omics to real-world disease research.
What types of data are expected to be included in DSS studies?
DSS studies are expected to integrate multi-omics data with rich phenotypic/clinical information and environmental exposure data, explicitly including social determinants of health (SDOH).
Why are social determinants of health (SDOH) explicitly included?
Including SDOH is part of the FOA's central goal: connecting molecular patterns with clinical and lived-environment factors in ways that can be compared and reused across diseases and study sites.
What are the main objectives of the DSS program across the consortium?
The DSS program has three main objectives across the consortium: (1) explore how multi-omics combined with phenotype and exposure/SDOH data can detect and characterize molecular profiles associated with healthy versus disease states; (2) develop broadly useful methods for data harmonization, integration, and analysis, along with best practices and standards for consistency and comparability; and (3) produce a high-value multi-dimensional dataset that will be made available to the wider research community.
What is meant by a "multi-dimensional" dataset in this context?
Based on the FOA description, the dataset is intended to bring together multiple types of omics data plus phenotypic/clinical measures and environmental exposure data (including SDOH), creating a resource that supports downstream research and methods development.
How does the DSS relate to other parts of the initiative?
The DSS awards are part of a larger coordinated initiative that also includes Omics Production Centers (RFA-HG-22-009) and a Data Analysis and Coordination Center (RFA-HG-22-010).
What is the expected role of a DSS within the consortium?
A DSS is expected to design and execute a disease-focused study while supporting consortium-wide learning. This includes developing and using strong enrollment and consent processes, collecting clinical/phenotypic and environmental exposure/SDOH data, collecting biological samples, and collaborating with NIH and other sites on protocols, analysis approaches, methods development, and coordinated data production and sharing.
Are longitudinal or repeated measures expected?
Yes, when appropriate. The FOA description states that DSS sites are expected to collect biological samples and other measures repeatedly over time when appropriate.
What does "Clinical Trial Optional" mean for this FOA?
"Clinical Trial Optional" means clinical trials are not required for all projects. Applicants may propose a clinical trial component if it fits the scientific plan and meets NIH requirements.
Who is the awarding agency?
The awarding agency is the National Institutes of Health (NIH).
What kinds of organizations are eligible to apply?
Eligibility is broad and includes many U.S.-based organization types, including: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other organizations.
Does the FOA encourage participation from specific institution types?
Yes. The FOA explicitly highlights participation from organizations such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, faith-based and community-based organizations, Hispanic-serving institutions, HBCUs, tribally controlled colleges and universities (TCCUs), regional organizations, and U.S. territories or possessions, aligning with the program emphasis on diversity and inclusion in study populations.
Are foreign (non-U.S.) organizations eligible to apply as the applicant?
No. Non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply.
Can a U.S. applicant include foreign collaborations or activities?
Yes, potentially. The FOA allows foreign components as defined by the NIH Grants Policy Statement, meaning a U.S. applicant may be able to include certain foreign activities or collaborations if they meet NIH policy requirements and are well-justified within the scope of the project.
What is the award ceiling listed for this opportunity?
The listed award ceiling is $500,000.
How many awards are expected?
The expected number of awards is not specified in the provided information.
When was this opportunity created?
The opportunity was created on 2022-09-07.
What was the original closing date?
The original closing date listed is 2022-11-18.
Which CFDA numbers are associated with this opportunity?
The opportunity is associated with CFDA numbers 93.113, 93.172, 93.396, and 93.399.
What is the intended impact for the broader research community?
The program aims to generate reusable datasets, methods, best practices, and standards. The resulting high-value multi-dimensional dataset is intended to be made available to the wider research community to support downstream discovery and method development beyond the funded sites.
What kind of collaboration is expected among awardees?
Because this is a consortium-based cooperative agreement, DSS teams are expected to participate in shared protocol development, collaborative analysis, methods development, and coordinated production and sharing of the final dataset, in coordination with NIH and other program partners.
Browse more opportunities from the same category: Education, Environment, Health
Next opportunity: Cooperative Agreement for CESU-affiliated Partner with Chesapeake Watershed Cooperative Ecosystem Studies Unit
Previous opportunity: Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HG 22 008
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HG 22 008) also looked into and applied for these:
| Funding Opportunity |
|---|
| Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed) Apply for RFA HG 22 010 Funding Number: RFA HG 22 010 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $950,000 |
| Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed) Apply for RFA HG 22 009 Funding Number: RFA HG 22 009 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $2,700,000 |
| The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) Apply for RFA OD 22 028 Funding Number: RFA OD 22 028 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $350,000 |
| Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional) Apply for PAR 23 042 Funding Number: PAR 23 042 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Genomic Community Resources (U24 Clinical Trial Not Allowed) Apply for PAR 23 085 Funding Number: PAR 23 085 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Biomedical Data Repository (U24 - Clinical Trials Not Allowed) Apply for PAR 23 079 Funding Number: PAR 23 079 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) Apply for PAR 23 078 Funding Number: PAR 23 078 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) Apply for RFA ES 23 004 Funding Number: RFA ES 23 004 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) Apply for PAR 23 109 Funding Number: PAR 23 109 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) Apply for PAR 23 139 Funding Number: PAR 23 139 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $275,000 |
| Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) Apply for RFA ES 23 001 Funding Number: RFA ES 23 001 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $2,000,000 |
| STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed) Apply for PAR 23 144 Funding Number: PAR 23 144 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $250,000 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 23 017 Funding Number: RFA OD 23 017 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $500,000 |
| Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Apply for PAR 23 184 Funding Number: PAR 23 184 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) Apply for RFA ES 23 011 Funding Number: RFA ES 23 011 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $275,000 |
| NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) Apply for PAR 23 229 Funding Number: PAR 23 229 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Apply for PA 23 263 Funding Number: PA 23 263 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed) Apply for PAR 23 237 Funding Number: PAR 23 237 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
| Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed) Apply for PAR 23 236 Funding Number: PAR 23 236 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: $350,000 |
| Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) Apply for PAR 23 299 Funding Number: PAR 23 299 Agency: National Institutes of Health Category: Education, Environment, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 22 008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.